about
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabul...
Read More
2.97
-0.07
(-2.30%)
260.5K
XNAS Volume
XNAS 24 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Veru Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..